# Efficacy and Safety of One-Stage Hybrid Coronary Revascularization

> **NCT04811586** · NA · UNKNOWN · sponsor: **Shanghai East Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Multivessel Coronary Artery Disease

## Interventions

- **PROCEDURE:** coronary revascularization

## Key facts

- **NCT ID:** NCT04811586
- **Lead sponsor:** Shanghai East Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-12-30
- **Primary completion:** 2021-12-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2021-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04811586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04811586, "Efficacy and Safety of One-Stage Hybrid Coronary Revascularization". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04811586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*